| Bardoxolone Data Shows Patient Improvement - Drug Discovery Development |
|
|
Drug Discovery & Development The data were also presented at the 2011 European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress in Prague, Czech Republic. The Phase 2 dose-finding clinical trial, known as the BEAM study, showed that in patients ... Kidney improvement sustained by Abbott drug-study Reuters Abbott Inflammation Drug Reverses Kidney Decline in Diabetics, Study Finds Bloomberg New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone |